Semglee

Viatris Patient Assistance Program Patient Guide: How to Get Semglee (insulin glargine-yfgn) at Low or No Cost

Semglee (insulin glargine-yfgn) is an affordable, interchangeable biosimilar to Lantus, a long-acting insulin used to help control blood sugar levels in adults and children with type 1 diabetes or adults with type 2 diabetes. The Viatris Patient Assistance Program (PAP) offers this medication free of charge to qualifying uninsured or underinsured U.S. residents who meet financial need criteria[1][2][3].

About Semglee and Why Assistance Matters

Semglee is a prescription insulin that provides a steady release of insulin over 24 hours, helping maintain stable blood glucose levels between meals and overnight. It's administered via subcutaneous injection once daily and comes in pre-filled pens or vials. As a biosimilar, Semglee matches the efficacy, safety, and quality of its reference product but is typically lower cost, making it accessible for diabetes management[1].

Diabetes affects millions, and insulin is a lifelong necessity. Without insurance or with high costs, patients risk poor control, leading to complications like neuropathy, kidney disease, or heart issues. The Viatris PAP bridges this gap by providing free Semglee for up to 12 months (with up to 11 refills) to eligible patients, easing financial burdens and supporting adherence[3][6].

Who Qualifies for the Program?

Eligibility focuses on financial need, residency, insurance status, and a valid prescription. Key requirements include:

• U.S. resident (including territories)[2][3].
• Financial hardship: Income must meet program thresholds (individually assessed; proof required)[1][2].
• Uninsured or underinsured: Fully uninsured preferred; no prescription drug coverage (Medicare Part D, Medicaid, etc., may disqualify unless specific state insulin programs apply)[2][3][4].
• Prescription for an FDA-approved use by a licensed U.S. healthcare provider[2].

Note: Medicare patients are generally ineligible due to prescription coverage requirements, but check state-specific insulin assistance (e.g., Colorado's Continuing Need State Insulin Program)[4].

Income Eligibility Breakdown

Specific Federal Poverty Level (FPL) percentages or household size thresholds are not publicly detailed online; eligibility is individually assessed based on provided income proof. Common PAPs use 400-500% FPL, but Viatris evaluates case-by-case[1][2].

*Estimates for 2026 continental U.S. FPL; actual thresholds vary. Contact program for exact assessment[1].

Insurance Requirements

• Primary: Must be fully uninsured or have no prescription drug coverage (e.g., no Medicare Part D, Medicaid, Tricare)[2][3][7].
• Underinsured patients may qualify if they lack drug coverage and meet income criteria[1].
• Medicare: Typically ineligible[4][9].
• Provider verifies status; incomplete info delays approval[2].

Step-by-Step Application Process

The program supports multiple application methods: phone, fax, email, or online via Viatris site[1][2][4][5].

1. Confirm Eligibility: Visit viatris.com, select Semglee, and check criteria. Call (800) 796-9526 or 888-417-5782 (M-F, 8AM-5PM CST/EST) for questions[1][2][5].

2. Gather Documents:

   • Proof of income: Recent tax return, pay stubs (last 3 months), W-2, or notarized statement[2][9].
   • Proof of insurance status: Insurance denial letter or certification of no coverage[2].
   • Prescription details from prescriber (name, NPI, signature)[2][3].
   • Patient ID (SSN last 4 digits, DOB, address)[2].

3. Complete Application: Download from viatris.com (insulin-specific form) or request by phone. Prescriber and patient must sign[2][4].

4. Submit:

   • Phone: (800) 796-9526 or 888-417-5782[1][5].
   • Fax: 866-792-7945, 877-427-7290, or insulin-specific[2][3][4].
   • Email: ViatrisPAP@Cardinalhealth.com or ViatrisPAP@viatris.com[2][3].
   • Online portal for some support[10].

5. Follow Up: Program notifies within 5 business days if more info needed; decision in 3 business days after[4].

Timeline and Delivery

• Processing: 3-5 business days post-complete submission[4].
• Approval Duration: 12 months, up to 11 refills[3][6].
• Delivery: Shipped free to patient's home or physician's office[1].
• Reauthorization: Required annually; resubmit proof[3]. Track via phone or portal[10].

Alternatives if Denied or Ineligible

• Biosimilar Alternative: Rezvoglar (another insulin glargine option; check Viatris PAP)[provided].
• Other insulins: MySemglee savings card (if insured), NeedyMeds.org, RxAssist.org[5][7].
• State programs (e.g., Colorado insulin for insured)[4].
• Generic insulins or 340B clinics.

Important Disclaimer

This guide is for informational purposes based on available program details as of 2026. Eligibility, terms, and contacts may change; always verify with Viatris at (800) 796-9526 or viatris.com. Not medical advice—consult your doctor for treatment. Viatris PAP does not guarantee approval; applications are assessed individually[1][2]. Word count: 1028.